학술논문
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion
Document Type
Article
Author
Moorman, A.V.; Schwab, C.; Winterman, E.; van Delft, F.W.; Harrison, C.J.; Hancock, J.; Castleton, A.; Cummins, M.; Moppett, J.; Gibson, B.; Goulden, N.; Samarasinghe, S.; Vora, A.; Kearns, P.; James, B.; Kirkwood, A.A.; Lancaster, D.; Madi, M.; McMillan, A.; Motwani, J.; Norton, A.; O’Marcaigh, A.; Patrick, K.; Bhatnagar, N.; Qureshi, A.; Richardson, D.; Stokley, S.; Taylor, G.
Source
In: British Journal of Haematology . (British Journal of Haematology, December 2020, 191(5):844-851)
Subject
Language
English
ISSN
13652141
00071048
00071048